• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
35.58
879.15
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.07
 

tata steel ltd
ITI reports consolidated net profit of Rs 375.14 crore in the March 2026 quarter
May 30,2026
Net profit of ITI reported to Rs 375.14 crore in the quarter ended March 2026 as against net loss of Rs 4.38 crore during the previous quarter ended March 2025. Sales declined 39.98% to Rs 627.65 crore in the quarter ended March 2026 as against Rs 1045.70 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 292.83 crore in the year ended March 2026 as against net loss of Rs 214.89 crore during the previous year ended March 2025. Sales declined 39.62% to Rs 2183.72 crore in the year ended March 2026 as against Rs 3616.42 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales627.651045.70 -40 2183.723616.42 -40
OPM %-17.74-2.69 -2.00-1.66 -
PBDT-178.94-37.87 -373 -99.87-180.73 45
PBT-83.90-66.79 -26 -156.32-249.93 37
NP375.14-4.38 LP 292.83-214.89 LP